Corporate announcements

We herewith submit the Unaudited Financial Results along with Limited Review report for the Quarter and Half year ended September 30, 2026

We herewith submit the Unaudited Financial Results along with Limited Review report for the Quarter and Half year ended September 30, 2026

We herewith submit the Unaudited Financial Results along with Limited Review report for the Quarter and Half year ended September 30, 2026

We herewith submit the Unaudited Financial Results along with Limited Review report for the Quarter and Half year ended September 30, 2026

We herewith submit the Unaudited Financial Results along with Limited Review report for the Quarter and Half year ended September 30, 2026

We herewith submit the Unaudited Financial Results along with Limited Review report for the Quarter and Half year ended September 30, 2026

We herewith submit the Unaudited Financial Results along with Limited Review report for the Quarter and Half year ended September 30, 2026

We refer to our earlier Letter No. CFPL/SEC/BSE/009/2026-2027 dated 29th October, 2026 informing you that the meeting of the Board of Directors is convened on Tuesday, 3rd November, 2026 to consider amongst other business, the consideration of Unaudited Financial Results for the Quarter and Half Financial Year ended on 30th September, 2026 along with the Statement of Assets and Liabilities as on 30th September, 2026 and Statement of Cash Flows for the Quarter and Half Financial Year ended 30th September, 2026. Accordingly, the meeting of Board of Directors was held today in which the Board of

Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2026 ,inter alia, to consider and approve To consider and approve, Unaudited Financial Results for the quarter ended 30th September,2026 along with the Limited Review Report thereon.

Please find attached Outcome for the Board Meeting Held on Tuesday, November 03, 2026.

Tourism Finance Corporation of India Limited has informed the Exchange regarding 'Investor Presentation'.

GK Energy Limited has informed the Exchange about Copy of Newspaper Publication regarding dispatch of Postal Ballot Notice and remote e-voting information.

Monitoring Agency Report for the quarter ended September 30. 2026.

Monitoring Agency Report for the quarter ended September 30, 2026

Supreme Infrastructure India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve Proposal for the issuance of non-convertible debentures ("NCDs") by the Company.

Sandur Manganese & Iron Ores Limited has informed the Exchange regarding Resignation of Mrs Latha Pillai as Independent Director of the company w.e.f. November 04, 2026.

Audio recording of conference call with Analysts/Institutional Investors held on 3rd November, 2026

Awfis Space Solutions Limited has informed the Exchange regarding Appointment of Ms. Juhi Garg as Company Secretary & Compliance Officer of the company w.e.f. November 11, 2026.

Uflex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve Unaudited Financial Results of the Company for the quarter and six months ended 30th September 2026

Resignation of Independent Director

We hereby inform you that at the meeting of the Board of Directors of the Company held today i.e. on Tuesday, 03rd November, 2026 at the registered office, the Board, inter alia, considered and approved the Standalone Unaudited Financial Results of the Company for the second quarter and half year ended 30th September, 2026 together with the Limited Review Report of the Statutory Auditors, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. PFA herewith 1. Unaudited Financial Results (Standalone) of the Company for the second quarter and ha

Outcome of Board meeting held on 03-11-2026

Statement of deviation/variation in the use of issue proceeds raised from listed NCD for second quarter ended September 30 ,2026

Statement of deviation/variation in the use of issue proceeds raised from listed NCD for second quarter ended September 30 ,2026

Statement of deviation/variation in the use of issue proceeds raised from listed NCD for second quarter ended September 30 ,2026

Statement of deviation/variation in the use of issue proceeds raised from listed NCD for second quarter ended September 30 ,2026

Statement of deviation/variation in the use of issue proceeds raised from listed NCD for second quarter ended September 30 ,2026

Statement of deviation/variation in the use of issue proceeds raised from listed NCD for second quarter ended September 30 ,2026

Statement of deviation/variation in the use of issue proceeds raised from listed NCD for second quarter ended September 30 ,2026

Statement of deviation/variation in the use of issue proceeds raised from listed NCD for second quarter ended September 30 ,2026

Statement of deviation/variation in the use of issue proceeds raised from listed NCD for second quarter ended September 30 ,2026

Statement of deviation/variation in the use of issue proceeds raised from listed NCD for second quarter ended September 30 ,2026

Statement of deviation/variation in the use of issue proceeds raised from listed NCD for second quarter ended September 30 ,2026

Statement of deviation/variation in the use of issue proceeds raised from listed NCD for second quarter ended September 30 ,2026

Statement of deviation/variation in the use of issue proceeds raised from listed NCD for second quarter ended September 30 ,2026

Statement of deviation/variation in the use of issue proceeds raised from listed NCD for second quarter ended September 30 ,2026

Statement of deviation/variation in the use of issue proceeds raised from listed NCD for second quarter ended September 30 ,2026

Financial results for the quarter ended on September 30, 2026

Outcome of the Board Meeting held on 03.11.2026 for approval of unaudited financial results for the quarter and half year ended September 2026 alognwith Limited Review Report of the Auditors thereon

Board of Directors of the Company at their meeting held on November 03, 2026 have approved the Unaudited Financial Results of the Company for the quarter and nine months ended on September 30, 2026

Ceinsys Tech Limited has informed the Exchange about Incorporation of Joint Venture Company.

Audio Recording of Investors Meet / Analysts ConCall held on Tuesday, November 03, 2026.

Integrated Financial result for quarter and nine months ended on 30.09.2026

Bank of Baroda has informed the Exchange about Intimation Regarding Shifting of Corporate Office of The Registrar and Share Transfer Agent (RTA) of the Bank

This is in relation to the captioned Buyback, the Company hereby submits the daily report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on Tuesday, November 03, 2026

Voluntary Disclosure of Information pursuant to Regulation 51 of SEBI (LODR), 2015.

RESULTS FOR QUARTER AND HALF YEAR ENDED 30 SEPTEMBER 2026

Amrutanjan Health Care Limited has informed the Exchange that Record date for the purpose of Dividend is 07-Nov-2026.

Intimation regarding change in corporate office address of RTA of the Company is attached herewith

Intimation regarding change in corporate office address of RTA of the Company is attached herewith